Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Other financing activities (2024 - 2026)

Prelude Therapeutics' Other financing activities history spans 3 years, with the latest figure at $294000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities fell 92.33% to $294000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $18.4 million, a 16.32% increase, with the full-year FY2025 number at $11.9 million, up 10730.0% from a year prior.
  • Other financing activities hit $294000.0 in Q1 2026 for Prelude Therapeutics, down from $11.9 million in the prior quarter.
  • Over the last five years, Other financing activities for PRLD hit a ceiling of $11.9 million in Q4 2025 and a floor of $294000.0 in Q1 2026.
  • Historically, Other financing activities has averaged $5.0 million across 3 years, with a median of $4.7 million in 2024.
  • Biggest five-year swings in Other financing activities: crashed 30.92% in 2025 and later crashed 92.33% in 2026.
  • Tracing PRLD's Other financing activities over 3 years: stood at $5.9 million in 2024, then skyrocketed by 101.03% to $11.9 million in 2025, then tumbled by 97.53% to $294000.0 in 2026.
  • Business Quant data shows Other financing activities for PRLD at $294000.0 in Q1 2026, $11.9 million in Q4 2025, and $2.4 million in Q3 2025.